Cefepime–Taniborbactam in Complicated Urinary Tract Infection-Reference-Cited by-同舟云学术

Cefepime–Taniborbactam in Complicated Urinary Tract Infection

Published:2024-02-15 Issue:7 Volume:390 Page:611-622
ISSN:0028-4793
Container-title:New England Journal of Medicine
language:en
Short-container-title:N Engl J Med

Author:

Wagenlehner Florian M.¹,Gasink Leanne B.¹,McGovern Paul C.¹^ORCID,Moeck Greg¹,McLeroth Patrick¹,Dorr MaryBeth¹,Dane Aaron¹,Henkel Tim¹

Affiliation:

1. From Justus Liebig University, Giessen, Germany (F.M.W.); LBG Consulting, Philadelphia (L.B.G.), and Venatorx Pharmaceuticals, Malvern (P.C.M., G.M., M.D., T.H.) — both in Pennsylvania; Fortrea, Burlington, NC (P.M.); and DaneStat Consulting, Macclesfield, United Kingdom (A.D.).

Funder

Global Antibiotic Research and Development Partnership

Biomedical Advanced Research and Development Authority

Everest Medicines

Publisher

Massachusetts Medical Society

Link

http://www.nejm.org/doi/pdf/10.1056/NEJMoa2304748

Reference38 articles.

1. Descriptive Epidemiology and Outcomes of Hospitalizations With Complicated Urinary Tract Infections in the United States, 2018

2. Attributable clinical and economic burden of carbapenem-non-susceptible Gram-negative infections in patients hospitalized with complicated urinary tract infections

3. Cost of hospitalised patients due to complicated urinary tract infections: a retrospective observational study in countries with high prevalence of multidrug-resistant Gram-negative bacteria: the COMBACTE-MAGNET, RESCUING study

4. Antimicrobial resistance in the EU/EEA (EARS-Net): annual epidemiological report for 2021. Stockholm: European Centre for Disease Prevention and Control, November 2022.

5. No time to wait: securing the future from drug-resistant infections: report to the Secretary-General of the United Nations. Geneva: World Health Organization, April 29, 2019.

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ARGONAUT-III and -V: susceptibility of carbapenem-resistant Klebsiella pneumoniae and multidrug-resistant Pseudomonas aeruginosa to the bicyclic boronate β-lactamase inhibitor taniborbactam combined with cefepime;Antimicrobial Agents and Chemotherapy;2024-09-04

2. Cefepime–Taniborbactam: A Novel Cephalosporin/β-Lactamase Inhibitor Combination;Drugs;2024-08-30

3. New antibiotics in clinical pipeline for treating infections caused by metallo-β-lactamases producing Gram-negative bacteria;Current Opinion in Infectious Diseases;2024-08-01

4. Novel Antibiotics for Urinary Tract Infection (UTI): The EAGLE 2 and EAGLE-3 Trials for Uncomplicated UTI, and the CERTAIN-1 Trial for Complicated UTI;European Urology Focus;2024-08

5. New Agents Are Coming, and So Is the Resistance;Antibiotics;2024-07-13